We are live on ! Find out more
LYRA

LYRA THERAPEUTICS INC
LYRA

Delisted

LYRA was delisted on the 16th of March, 2026.

Back to rankings

1 hedge funds and large institutions have $51.1K invested in LYRA THERAPEUTICS INC in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

13.67% less ownership

Funds ownership: 13.67% → 0% (-14%)

93% less capital invested

Capital invested by funds: $747K → $51.1K (-$696K)

96% less funds holding

Funds holding: 23 → 1 (-22)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 20

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
-22
Holders Change %
-95.65%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$130K
2
IC
Ikarian Capital
Texas
-$65.2K
3
DS
DRW Securities
Illinois
-$51.8K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$37.7K
5
AGP
Artia Global Partners
Florida
-$27K

LYRA Hedge Fund Activity: Q1 2026 in Review

1 of the 8,204 institutional investors tracked by Wall St. Rank reported a position in LYRA THERAPEUTICS INC (LYRA) for Q1 2026, worth a combined $51.1K — down 93% from $747K a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of LYRA and 0 opened new positions — a net loss of 20 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Sabby Management, cutting an estimated $130K.

  • 1 institutional investor held LYRA THERAPEUTICS INC (LYRA) as of Q1 2026, down from 23 in Q4 2025.
  • Funds reported $51.1K of LYRA THERAPEUTICS INC stock for Q1 2026, down 93% quarter-over-quarter.
  • 0 funds opened new LYRA THERAPEUTICS INC positions in Q1 2026 and 20 closed out, a net change of -20 holders.
  • The largest LYRA THERAPEUTICS INC seller in Q1 2026 was Sabby Management, an estimated $130K sold.

Based on aggregated 13F filings for Q1 2026.